Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar-Aug;2(1):100112.
Epub 2016 Nov 16.

QOL and Survival Comparisons by Race in Oncology Clinical Trials

A D Tan  1 , P J Novotny  1 , J S Kaur  2 , J C Buckner  2 , R B Mowat  3 , E Paskett  4 , J A Sloan  1
Affiliations

QOL and Survival Comparisons by Race in Oncology Clinical Trials

A D Tan et al. J Cancer Clin Oncol. 2016 Mar-Aug.

Abstract

Background: Significant efforts have been made to increase access and accrual to clinical trials for minority cancer patients (MP). This meta-analysis looked for differences in survival and baseline quality of life (QOL) between MP and non-minority cancer patients (NMP).

Materials and methods: Baseline QOL and overall survival times from 47 clinical trials (6513 patients) conducted at Mayo Clinic Cancer Center/North Central Cancer Treatment Group were utilized. Assessments included Uniscale, Linear Analogue Self Assessment, Symptom Distress Scale (SDS), Profile of Mood States and Functional Assessment of Cancer Therapy - General, each transformed into a 0-100 scale with higher scores indicating better outcomes. This transformation involves subtracting the lowest possible value from the assessment, dividing by the range of the scale (the maximum minus the minimum), and multiplying by 100. Analyses included Fisher's Exact tests, linear regression, Kaplan-Meier curves, and Cox proportional hazards models.

Results: Eight percent of patients self-reported as MP (0.45% American Indian/Alaskan Native, 0.7% Asian, 5% Black/African American, 1.5% Hispanic, 0.1% Native Hawaiian and 0.3% Other). MP had no meaningful deficits relative to non-MP in overall QOL but were slightly worse on FACT-G total score, physical, social/family, functional, and SDS nausea severity. MP with lung, neurological or GI cancers had significantly worse mean scores in nausea (58 vs. 69), sleep problems (34 vs. 54); emotional (53 vs. 74); and social/family (60 vs. 67), respectively. Regression models confirmed these results. After adjusting for disease site, there were no significant differences in survival.

Conclusion: MP on these clinical trials indicated small deficits in physical, social, and emotional subscales at baseline compared to NMP. Within cancer sites, MP experienced large deficits for selected QOL domains that bear further attention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall Survival Times by Minority Status
Figure 2
Figure 2
Overall QOL Assessment Scores by Minority Status
See this image and copyright information in PMC

References

    1. Kaluzny A, Brawley O, Garson-Angert D, Shaw J, Godley P, et al. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst. 1993;85:1945–1950. - PubMed
    1. Adams-Campbell LL, Ahaghotu C, Gaskins M, Dawkins FW, Smoot D, et al. Enrollment of African Americans onto clinical treatment trials: study design barriers. J Clin Oncol. 2004;22:730–734. - PubMed
    1. Lara PN, Jr, Higdon R, Lim N, Kwan K, Tanaka M, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19:1728–1733. - PubMed
    1. Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, et al. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer. 2003;97:1499–1506. - PubMed
    1. Bolen S, Tilburt J, Baffi C, Gary TL, Powe N, et al. Defining “success” in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach. Cancer. 2006;106:1197–1204. - PubMed

LinkOut - more resources